Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-1.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
-$3.22B
(-5.6%)
Cap. Flow
-$953M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
985
New
115
Increased
314
Reduced
359
Closed
149
Top Buys
| 1 |
Hubbell
HUBB
|
+$208M |
| 2 |
Norfolk Southern
NSC
|
+$145M |
| 3 |
Insmed
INSM
|
+$137M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$136M |
| 5 |
Soleno Therapeutics
SLNO
|
+$116M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$355M |
| 2 |
Royalty Pharma
RPRX
|
+$334M |
| 3 |
McDonald's
MCD
|
+$198M |
| 4 |
Union Pacific
UNP
|
+$188M |
| 5 |
HES
Hess
HES
|
+$182M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Generac Holdings
GNRC
$10.9B
| $3.72M | 0.01% |
29,358
-81,200
| -73% | -$10.3M |
|
727
Evolent Health
EVH
$1.07B
| $3.61M | 0.01% |
381,547
-462,957
| -55% | -$4.38M |
|
728
Live Nation Entertainment
LYV
$39.6B
| $3.6M | 0.01% |
27,600
+11,600
| +73% | +$1.51M |
|
729
Dianthus Therapeutics
DNTH
$1.22B
| $3.43M | 0.01% |
189,000
+9,000
| +5% | +$163K |
|
730
Community Trust Bancorp
CTBI
$1.04B
| $3.4M | 0.01% |
67,499
+47,499
| +237% | +$2.39M |
|
731
Pan American Silver
PAAS
$15.3B
| $3.36M | 0.01% |
130,000
-30,000
| -19% | -$775K |
|
732
Toast
TOST
$23.3B
| $3.32M | 0.01% |
+100,000
| New | +$3.32M |
|
733
Waste Connections
WCN
$45.3B
| $3.28M | 0.01% |
+16,809
| New | +$3.28M |
|
734
Genuine Parts
GPC
$19.4B
| $3.2M | 0.01% |
26,900
-66,415
| -71% | -$7.91M |
|
735
KalVista Pharmaceuticals
KALV
$775M
| $3.19M | 0.01% |
276,000
-24,000
| -8% | -$277K |
|
736
Astria Therapeutics
ATXS
$423M
| $3.14M | 0.01% |
588,200
-125,000
| -18% | -$668K |
|
737
News Corp Class B
NWS
$17.8B
| $3.1M | 0.01% |
101,934
-2,700
| -3% | -$82K |
|
738
Pinnacle Financial Partners
PNFP
$7.58B
| $3.08M | 0.01% |
+29,000
| New | +$3.08M |
|
739
Pebblebrook Hotel Trust
PEB
$1.36B
| $3.01M | 0.01% |
296,761
-3,239
| -1% | -$32.8K |
|
740
Akamai
AKAM
$11B
| $2.99M | 0.01% |
37,100
-3,300
| -8% | -$266K |
|
|
LAC
741
Lithium Americas
LAC
$677M
| $2.98M | 0.01% |
1,100,000
| – | – |
|
742
Procept Biorobotics
PRCT
$2.09B
| $2.91M | 0.01% |
+50,000
| New | +$2.91M |
|
743
Lifezone Metals
LZM
$357M
| $2.82M | 0.01% |
674,854
| – | – |
|
744
Nutanix
NTNX
$20.7B
| $2.79M | 0.01% |
+40,000
| New | +$2.79M |
|
745
C.H. Robinson
CHRW
$15.1B
| $2.79M | 0.01% |
27,228
+8,300
| +44% | +$850K |
|
746
Trevi Therapeutics
TRVI
$1.17B
| $2.77M | 0.01% |
440,000
-2,060,000
| -82% | -$13M |
|
747
Okta
OKTA
$15.9B
| $2.63M | ﹤0.01% |
25,000
-325,000
| -93% | -$34.2M |
|
748
Silgan Holdings
SLGN
$4.71B
| $2.51M | ﹤0.01% |
+49,033
| New | +$2.51M |
|
|
KMTS
749
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$934M
| $2.49M | ﹤0.01% |
+100,000
| New | +$2.49M |
|
750
C4 Therapeutics
CCCC
$188M
| $2.48M | ﹤0.01% |
1,550,000
| – | – |
|